Share information

Genovis shares are traded on NASDAQ OMX FirstNorth, Stockholm, under the short name GENO. On June 30 the Company had 69 237 120 shares and 2,692 shareholders. NASDAQ OMX First North is an alternative market, operated by the different exchanges within NASDAQ OMX. It does not have the legal status as an EU-regulated market. Companies at First North are subject to the rules of First North and not the legal requirements for admission to trading on a regulated market. The risk in such an investment may be higher than on the main market. The Company's Certified Adviser is Thenberg & Kinde Fondkommission AB.+46 (31) 745 50 00.